Target intelligence / Profile preview

Plasma membrane phospholipids and general membrane structures

Molecular classification
Lipid, Phospholipid, Structural component
01

Overview

The plasma membrane is a fundamental biological structure composed of a phospholipid bilayer interspersed with proteins and sterols, serving as the primary barrier between the intracellular and extracellular environments (Molecular Biology of the Cell, 4th ed.). It plays a vital role in maintaining cellular integrity, regulating the transport of ions and molecules, and facilitating signal transduction through lipid-protein interactions. In therapeutic contexts, the membrane and its constituent phospholipids are targeted primarily by antimicrobial and antifungal agents that exploit biochemical differences between host and pathogen membranes, such as the presence of ergosterol in fungi or specific anionic lipids in bacteria (PubMed, PMID: 31503155). For example, polyene antifungals like amphotericin B create lethal pores by binding to membrane sterols, while lipopeptide antibiotics like daptomycin cause rapid depolarization by inserting into the lipid matrix (StatPearls, 2023). Despite their efficacy, drugs targeting general membrane structures often face challenges related to systemic toxicity and a narrow therapeutic window because of the structural similarities between human and microbial lipid bilayers (NIH, 2022).

Other names
Cell membraneLipid bilayerPlasma membrane lipidsMembrane phospholipidsCytoplasmic membrane
02

Mechanism of action

Drugs targeting membrane structures typically act through physical disruption, such as pore formation, sequestration of essential lipids like ergosterol, or alteration of membrane tension and fluidity, leading to loss of cytoplasmic contents and cell death (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Barrier functionSignal transductionCellular compartmentalizationIon homeostasisMembrane traffickingCell-cell recognition
04

Disease associations

InfectionCancerNeurodegenerative diseaseInflammation
05

Safety considerations

HemolysisNephrotoxicityNeurotoxicityLow therapeutic index due to lack of specificity between host and pathogen membranes
06

Interacting drugs

Amphotericin B

7 more in the full profile.

07

Biomarkers

Lipidomic profileMembrane permeabilityPhosphatidylserine exposureAnnexin V binding

Beyond the preview

Go deeper on Plasma membrane phospholipids and general membrane structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma membrane phospholipids and general membrane structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call